These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 31281287)

  • 1. Potential of Prebiotic Butyrogenic Fibers in Parkinson's Disease.
    Cantu-Jungles TM; Rasmussen HE; Hamaker BR
    Front Neurol; 2019; 10():663. PubMed ID: 31281287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wood-Derived Dietary Fibers Promote Beneficial Human Gut Microbiota.
    La Rosa SL; Kachrimanidou V; Buffetto F; Pope PB; Pudlo NA; Martens EC; Rastall RA; Gibson GR; Westereng B
    mSphere; 2019 Jan; 4(1):. PubMed ID: 30674645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buty and the beast: the complex role of butyrate in Parkinson's disease.
    Elford JD; Becht N; Garssen J; Kraneveld AD; Perez-Pardo P
    Front Pharmacol; 2024; 15():1388401. PubMed ID: 38694925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in developing butyrogenic functional foods to promote gut health.
    Zhang M; Li RW; Yang H; Tan Z; Liu F
    Crit Rev Food Sci Nutr; 2024; 64(13):4410-4431. PubMed ID: 36330804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prebiotic effects: metabolic and health benefits.
    Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
    Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open label, non-randomized study assessing a prebiotic fiber intervention in a small cohort of Parkinson's disease participants.
    Hall DA; Voigt RM; Cantu-Jungles TM; Hamaker B; Engen PA; Shaikh M; Raeisi S; Green SJ; Naqib A; Forsyth CB; Chen T; Manfready R; Ouyang B; Rasmussen HE; Sedghi S; Goetz CG; Keshavarzian A
    Nat Commun; 2023 Feb; 14(1):926. PubMed ID: 36801916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered gut microbiota and intestinal permeability in Parkinson's disease: Pathological highlight to management.
    Sharma S; Awasthi A; Singh S
    Neurosci Lett; 2019 Nov; 712():134516. PubMed ID: 31560998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designing future prebiotic fiber to target metabolic syndrome.
    Jakobsdottir G; Nyman M; Fåk F
    Nutrition; 2014 May; 30(5):497-502. PubMed ID: 24262515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vitro Effects of Dietary Inulin on Human Fecal Microbiota and Butyrate Production.
    Jung TH; Jeon WM; Han KS
    J Microbiol Biotechnol; 2015 Sep; 25(9):1555-8. PubMed ID: 26095388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-edged sword: Role of butyrate in the oral cavity and the gut.
    Guan X; Li W; Meng H
    Mol Oral Microbiol; 2021 Apr; 36(2):121-131. PubMed ID: 33155411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinson's disease patients' short chain fatty acids production capacity after in vitro fecal fiber fermentation.
    Baert F; Matthys C; Maselyne J; Van Poucke C; Van Coillie E; Bergmans B; Vlaemynck G
    NPJ Parkinsons Dis; 2021 Aug; 7(1):72. PubMed ID: 34389734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prebiotic UG1601 mitigates constipation-related events in association with gut microbiota: A randomized placebo-controlled intervention study.
    Chu JR; Kang SY; Kim SE; Lee SJ; Lee YC; Sung MK
    World J Gastroenterol; 2019 Oct; 25(40):6129-6144. PubMed ID: 31686768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.
    Caputi V; Giron MC
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain-gut-microbiota axis in Parkinson's disease.
    Mulak A; Bonaz B
    World J Gastroenterol; 2015 Oct; 21(37):10609-20. PubMed ID: 26457021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High purity galacto-oligosaccharides enhance specific Bifidobacterium species and their metabolic activity in the mouse gut microbiome.
    Monteagudo-Mera A; Arthur JC; Jobin C; Keku T; Bruno-Barcena JM; Azcarate-Peril MA
    Benef Microbes; 2016; 7(2):247-64. PubMed ID: 26839072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prebiotic stimulation of human colonic butyrate-producing bacteria and bifidobacteria, in vitro.
    Scott KP; Martin JC; Duncan SH; Flint HJ
    FEMS Microbiol Ecol; 2014 Jan; 87(1):30-40. PubMed ID: 23909466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative
    Anand S; Kaur H; Mande SS
    Front Microbiol; 2016; 7():1945. PubMed ID: 27994578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arabinoxylans and inulin differentially modulate the mucosal and luminal gut microbiota and mucin-degradation in humanized rats.
    Van den Abbeele P; Gérard P; Rabot S; Bruneau A; El Aidy S; Derrien M; Kleerebezem M; Zoetendal EG; Smidt H; Verstraete W; Van de Wiele T; Possemiers S
    Environ Microbiol; 2011 Oct; 13(10):2667-80. PubMed ID: 21883787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prebiotic effects of diet supplemented with the cultivated red seaweed Chondrus crispus or with fructo-oligo-saccharide on host immunity, colonic microbiota and gut microbial metabolites.
    Liu J; Kandasamy S; Zhang J; Kirby CW; Karakach T; Hafting J; Critchley AT; Evans F; Prithiviraj B
    BMC Complement Altern Med; 2015 Aug; 15():279. PubMed ID: 26271359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health Effects and Sources of Prebiotic Dietary Fiber.
    Carlson JL; Erickson JM; Lloyd BB; Slavin JL
    Curr Dev Nutr; 2018 Mar; 2(3):nzy005. PubMed ID: 30019028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.